findmyKOL
Clinical trialNCT06333262RecruitingPhase 2Interventional

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

SponsorInhye AhnEnrollment60Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate fixed-duration therapy with pirtobrutinib and obinutuzumab given over 12 cycles (approximately 1 year) as first-line treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL or SLL).
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • New England Cancer Specialists

    Scarborough, Maine, United States

    John P Winters, III, MD
    Recruiting
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

    Jon Arnason, MD
    Recruiting
  • Brigham & Women'S Hospital

    Boston, Massachusetts, United States

    Inhye Ahn, MD
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Inhye Ahn, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Obinutuzumab →Pirtobrutinib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
22 Apr 2024
Primary completion
1 Jul 2027
Completion
1 Jul 2032
Last update posted
21 Jan 2026
Registered enrollment
60
Registry id
NCT06333262
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.